In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, today announced the launch of its new MicroCNX® ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Taysha Gene Therapies offers hope for Rett syndrome with innovative treatment, strong trial results, and promising regulatory ...

Jason Foster, CEO of Ori Biotech, discusses the difficulties preventing more widespread adoption of these advanced therapies.

Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...

New developments in regenerative medicine are providing alternative solutions that aim to address the underlying issues of ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches -- gene therapy ...

The study found that the number of advanced therapy Phase I trials in the UK nearly doubled since the same time in 2023.

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...